Tag: 233-7-million
-
Ablynx burns more cash in first-quarter on higher R&D costs
(Reuters) – Belgian biotech firm Ablynx said on Thursday it used up more cash than it made in the first quarter, driven by higher external research and development costs. Cash burn is a closely watched figure for rising biotech companies that generate revenue only from development milestone payments, and not drug sales. The group, which…
-
80 percent of world’s city dwellers breathing bad air: UN
Over 80 percent of the world's city dwellers breathe poor quality air, increasing their risk of lung cancer and other life-threatening diseases, a new World Health Organization (WHO) report warned Thursday. “Urban air pollution continues to rise at an alarming rate, wreaking havoc on human health,” Maria Neira, the head of WHO's department of public…